Table 2. Univariate and multivariate analyses of cancer special survival (CSS) and overall survival (OS) after propensity score matching (N = 188).
Variables | CSS | OS | ||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||
P-value | HR (95% CI) | P-value | P-value | HR (95% CI) | P-value | |
Age | 0.407 | NI | 0.491 | NI | ||
<40 | ||||||
40–60 | ||||||
>60 | ||||||
Race | 0.002 | 0.029 | 0.003 | 0.046 | ||
White | Reference | Reference | ||||
Black | 2.251 (1.186, 4.271) | 0.013 | 2.076 (1.102, 3.912) | 0.024 | ||
Other | 0.781 (0.270, 2.258) | 0.648 | 0.725 (0.252.2.084) | 0.551 | ||
Marital status | 0.204 | NI | 0.138 | NI | ||
Married | ||||||
Unmarried | ||||||
Unknown | NI | |||||
Grade | 0.108 | NI | 0.078 | |||
Grade I/II | ||||||
Grade III/IV | ||||||
Unknown | ||||||
AJCC stage | <0.001 | <0.001 | <0.001 | <0.001 | ||
IIIA | Reference | Reference | ||||
IIIB | 1.465 (0.645, 3.328) | 0.361 | 1.541 (0.702, 3.380) | 0.281 | ||
IV | 4.837(2.548, 9.180) | <0.001 | 4.475(2.387, 8.389) | <0.001 | ||
Breast Subtype | <0.001 | <0.001 | <0.001 | <0.001 | ||
Her2-/HoR+ | Reference | Reference | ||||
Her2+/HoR- | 0.870 (0.330, 2.294) | 0.778 | 0.820 (0.314, 2.143) | 0.686 | ||
Her2+/HoR+ | 0.244 (0.070, 0.857) | 0.028 | 0.225 (0.065, 0.785) | 0.019 | ||
Triple Negative | 3.387 (1.697, 6.762) | 0.001 | 3.188 (1.630, 6.235) | 0.001 | ||
Unknown | 1.988 (0.655, 6.036) | 0.225 | 1.897 (0.633, 5.685) | 0.253 | ||
Surgery | 0.843 | 0.307 | 0.738 | 0.254 | ||
Simple Mastectomy | Reference | Reference | ||||
Radical mastectomy | 1.493 (0.692, 3.222) | 1.556 (0.728, 3.323) | ||||
Chemotherapy | 0.459 | 0.637 | 0.438 | 0.549 | ||
No/unknown | Reference | Reference | ||||
Yes | 1.641 (0.209, 12.882) | 1.875 (0.241, 14.607) | ||||
PMRT | 0.013 | 0.030 | 0.006 | 0.013 | ||
No | Reference | Reference | ||||
Yes | 0.519 (0.287, 0.939) | 0.480 (0.269, 0.859) |
Notes.
Abbreviation
- HoR
- Hormone receptor
- CSS
- cancerspecific survival
- OS
- overall survival
- NI
- not included in the multivariate survival analysis
- PMRT
- post mastectomy radiotherapy